About Hämatologie-Onkologie Stolberg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Hämatologie-Onkologie Stolberg
During the past decade, Hämatologie-Onkologie Stolberg conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hämatologie-Onkologie Stolberg"
#1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hämatologie-Onkologie Stolberg
According to Clinical.Site data, the most researched conditions in "Hämatologie-Onkologie Stolberg" are
"Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials), "Myeloid Leukemia, Chronic" (1 trials) and "Stage IV Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Hämatologie-Onkologie Stolberg" in a lesser frequency.
Clinical Trials Intervention Types at Hämatologie-Onkologie Stolberg
Most popular intervention types in "Hämatologie-Onkologie Stolberg" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "dasatinib (SPRYCEL®)" (1 trials) and "eHealth system support for symptom management via CANKADO" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hämatologie-Onkologie Stolberg
The vast majority of trials in "Hämatologie-Onkologie Stolberg" are
3 trials for "All" genders.
Clinical Trials Status at Hämatologie-Onkologie Stolberg
Currently, there are NaN active trials in "Hämatologie-Onkologie Stolberg".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hämatologie-Onkologie Stolberg,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hämatologie-Onkologie Stolberg, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".